Under-the-Radar Cannabis Stock Plans Up-Listing to the TSX: Time to Buy?

MediPharm Labs Corp (TSXV:LABS) stock may graduate to the main TSX soon, should investors buy into the special event?

| More on:

Little known but red-hot marijuana growth stock MediPharm Labs Corp (TSXV:LABS) could enjoy further exposure after announcing its application to up-list from the TSX Venture Exchange to the main TSX yesterday, and there’s good reason to anticipate good returns on investment.

The company has been one of the hottest cannabis stocks so far in 2019 after reporting two consecutive quarters of positive EBITDA in record time. Its share price is trading over 200% high year-to-date, outperforming most other industry leading players except Village Farms International.

On Tuesday, the youthful marijuana player applied to graduate from the smaller TSX Venture Exchange platform and up-list its shares to the main Toronto Stock Exchange, the most esteemed, deepest and most liquid equities exchange in the country.

The TSXV has been an incubatory platform for future industry leaders, and MediPharm is seeking an approval to up-list to the main exchange to trade alongside such industry giants as Canopy Growth and Aurora Cannabis, whose shares once graced the TSXV during their early days.

Trade in the company’s shares debuted on the TSXV last year, and the Tuesday announcement of an application to up-list to the main exchange may was made in record time.

Why buy?

A graduation to the TSX could improve the investing public’s perception on the small issuer, as the company would have secured an approval from a stricter senior exchange, a huge vote of confidence by the leading capital market makers on the company’s execution on multiple administrative and financial deliverables.

MediPharm hasn’t enjoyed much media coverage yet, however. Up-listing to the main exchange could bring increased liquidity in the shares and better visibility for the stock. Some earlier graduates like Supreme Cannabis and HEXO enjoyed better valuations soon after announcing similar moves.

MediPharm Labs is laser-focused on cannabis extraction, distillation, purification and cannabinoid isolation from dried marijuana purchased from licensed producers. Its business model has already proven to be highly profitable.

New cannabis extracts tolling contracts, bigger private label agreements and new provincial supply agreements recently signed could allow business volumes to grow much faster than that of its closer peers.

Beware the risk!

It can be a rewarding short-term trading opportunity, but buying into a ticker at such special events is not a very sound long-term investment strategy. Company fundamentals can change dramatically during one’s investment horizon, so the business needs be analysed closely.

There has been a number of recent graduates from the incubatory TSXV market to the main exchange since 2018, but not all investors who bought into the expected volume surge have made the money.

For example, investors in Aleafia Health shares upon its graduation to the TSX in May this year are sitting over 30% losses at the time of writing, while Supreme Cannabis’ shares are trading much lower than their early February highs when trading migrated to the main exchange this year.

Marijuana industry stocks are probably undergoing the usual annual troughs witnessed over the most recent two years, and no one can tell when valuations can be expected to recover, especially given that the expected catalysts that historically supported industry hype aren’t that many post recreational legalisation, and recent edibles legislation has come in more restrictive than could have been desirable.

LABS shares have already enjoyed a massive rally this year, and they may be due for a massive correction.

Most noteworthy, MediPharm shares didn’t see a trading volume surge after the announcement on Tuesday, as the company has only made an application to the TSX without any assurance that the TSX will approve the application.

I would trade with caution.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool owns shares of Village Farms International, Inc.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »